click below
click below
Normal Size Small Size show me how
Allergic & Pseudoall
Allergic & Pseudoallergic Drug Rxns
Question | Answer |
---|---|
allergic and pseudoallergic rxns comprise how much reported adverse drug rxns | 24% |
how many basic types of drug allergy categories | 4 |
observed rxn in immunologically mediated drug rxns | do not resemble pharmacologic effect |
type of manifestation is similar to what with immunologically mediated drug rxns | similar to those seen with other allergic reactions (anaphylaxis, urticaria, serum sickness) |
between the first exposure to the drug and the reaction to the drug is what?? | lag time |
after the drug as been dc'd, what happens with the rxn | Resolved |
What can treat the adverse clinical signs and symptoms | Rash in limited areas - topical corticosteroid oral/iv antihistamine refractory/severe rxn - systemic corticosteroid burst |
Type I - immune response | IgE |
Type II - Immune response | IgG |
Type III Immune Response | IgG and IgM |
Type IV Immune Response | IVa - Th1 Cytokines, IVb - Th2 Cytokines, IVC- cytotoxic T cells, IVd-T cells |
Clinical Sx Type 1 | anaphylaxis, urticaria |
Clinical Sx Type II | hemolytic anemia, thrombocytopenia blood dyscrasias |
Clinical Sx Type III | Vasculitis, serum sickness, lupus |
Clinical Sx Type IV | a-tuberculin rxn, eczema b-maculopapular & bullous exanthema c-same as b also eczema, pustular exanthema d-pustular exanthema |
Potential causative drugs Type I | b-lactams - pcns, cephs, carbapenems non-b-lactams- sulfonamides, vanco others-insulin, heparin |
Potential causative drugs Type II | quinidine, methyldopa, pcns, heparin |
Potential causative drugs Type III | pcns, sulfonamides, radiocontrast agents, phenytoin |
Potential causative drugs Type IV | B-lacatams, sulfonamides, phenytoin |
Pseudoallergic Drug Rxns | clinically resemble immediate HSN allergic rxns but lack an immune basis |
pathophysiology of pseduoallergic drug rxns | unknown - considered subtype of idiopathic rxns |
w/ readministration of the drug what happens w/the reaction | rxn remains constant -whether mild or severe and are dose-related |
opiate pseudoallergic drug rxn | stimulate mast cell release directly, pruritis, urticaria, and occasionally mild wheezing - pretreat w/antihistamines |
radiocontrast media pseudoallergic drug rxn | serious, immediate pseudoallergic rxns |
anaphylaxis | acute, life-threatening allergic raxn w/MULTIPLE organ systems |
Clinical Presentation anaphylaxis - what systems | cutaneous rxn, respiratory dysfunction, cardiovascular complications, gi disturbances |
clinical presentations anaphylaxis - cutaneous rxn | flushing, pruritis, urticaria, angioedema |
clinical presentations anaphylaxis - respiratory dysfunction | SOB, tightness of throat or chest, etc |
clinical presentations anaphylaxis - CV complications | HOTN, syncope, altered mental status, CP, dysrhythmia |
clinical presentations anaphylaxis - GI disturbances | N/V/D |
grading of anaphylaxis | mild - skin/subq tissues only moderate- respiratory, CV, Gi involvement severe- hypoxia, HOTN, disordered CNS fxn |
Biphasic response of anaphylaxis | initial rxn - 30min-2h after antigen exposure 6-8hrs after antigen exposure anaphylaxis may return |
how long do you observe pt after anaphylactic rxn | greater than or equal to 12 hours |
pathophysiology of anaphylaxis | prior exposure ->IgE formation->Secondary ag exposure ->Crosslink IgE on mast cells and basophils -> release stored inflammatory mediators ->vasodilation ->increased vascular permeability |
IgE-mediated Antigens | Antibiotics MC, other meds, foods |
what position should you place pt w/anaphylaxis in | trendelenburg |
monitor VS when | q2-5 min, stay w/pt |
other anaphylaxis management | epinephrine, diphenhydramine or ranitidine, treat HOTN, hydrocortisone, may use glucagon |
when would you use glucagon for anaphylaxis management | refractory cases not responding to epinephrine because bb is complicating management |
when would you use ranitidine IV prn | may need to use w/diphenhydramine for H2 receptors |
chronic anaphylaxis management | trigger avoidance, immunotherapy, post-trigger self treatment, ID bracelet |
post-trigger self treatment includes what | Epi-Pen, Ana-Kit |